Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials.

Journal of Parkinson's disease - 1 Nov 2024

Marchand Félix, Blaise Anne-Sophie, Defebvre Luc, Cailliau Emeline, Bombois Stéphanie, Devos David, Moreau Caroline

Abstract excerpt

BACKGROUND: Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease with diverse clinical phenotypes, prompting the development of new diagnostic criteria known as the MDS-PSP classification. However, little is known about the prognostic value of this classification in order to better stratify patients for the clinical trials. OBJECTIVE: To assess the impact of the different clinical phenotypes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Deglutition Disorders

Share to Phenotype

Share to Prognosis

Share to Supranuclear Palsy, Progressive

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 39957197
DOI: 10.1177/1877718X241291996
PMCID: PMC13348317

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical prognostic factors in progressive supranuclear palsy: Implications for clinical trials.PMID 39957197Read ↗

The Progressive Supranuclear Palsy Clinical Deficits Scale (PSP-CDS) tracks longitudinal progression in PSPSemantic proximity Read ↗

Neuropathological validation of the MDS-PSP criteria with PSP and other frontotemporal lobar degenerationSemantic proximity Read ↗

Investigating differences in young- and late-onset progressive supranuclear palsy.Semantic proximity Read ↗

The diagnosis of progressive supranuclear palsy: current opinions and challenges.Semantic proximity Read ↗

Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.Semantic proximity Read ↗

Progressive Supranuclear Palsy: an Update.Semantic proximity Read ↗

The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.Semantic proximity Read ↗

Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.Semantic proximity Read ↗

Association of PSP phenotypes with survival: A brain-bank study.Semantic proximity Read ↗

The Progressive Supranuclear Palsy: Past and Present Aspects.Semantic proximity Read ↗

Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR-PSP)Semantic proximity Read ↗

Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.